Patents by Inventor Kurt Pingel

Kurt Pingel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Producing Factor VII Glycoforms
    Publication number: 20090281022
    Abstract: The present invention provides preparations of Factor VIIa polypeptides or Factor VIIa-related polypeptides that exhibit predetermined glycoform patterns. The preparations of the invention exhibit improved functional properties and are useful for treating Factor VII-mediated conditions.
    Type: Application
    Filed: July 15, 2009
    Publication date: November 12, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: HANS KURT PINGEL, Niels Kristian Klausen
  • FVII Specific Antibodies and Use Thereof
    Publication number: 20090017557
    Abstract: The present invention relates to novel antibodies against FVII, use for determining amount of correctly folded and intact FVII in a sample, as well as for purification and process optimization.
    Type: Application
    Filed: August 31, 2006
    Publication date: January 15, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Hans Kurt Pingel, Else Marie Nicolaisen, Janus Krarup
  • Factor VII glycoforms
    Patent number: 6903069
    Abstract: The present invention provides preparations of Factor VIIa polypeptides or Factor VIIa-related polypeptides that exhibit predetermined glycoform patterns. The preparations of the invention exhibit improved functional properties and are useful for treating Factor VII-mediated conditions.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: June 7, 2005
    Assignee: Novo Nordisk Health Care A/S
    Inventors: Hans Kurt Pingel, Niels Kristian Klausen
  • Factor VII glycoforms
    Publication number: 20020151471
    Abstract: The present invention provides preparations of Factor VIIa polypeptides or Factor VIIa-related polypeptides that exhibit predetermined glycoform patterns. The preparations of the invention exhibit improved functional properties and are useful for treating Factor VII-mediated conditions.
    Type: Application
    Filed: October 2, 2001
    Publication date: October 17, 2002
    Inventors: Hans Kurt Pingel, Niels Kristian Klausen
  • Factor VII glycoforms
    Publication number: 20020137673
    Abstract: The present invention provides preparations of Factor VIIa polypeptides or Factor VIIa-related polypeptides that exhibit predetermined glycoform patterns. The preparations of the invention exhibit improved functional properties and are useful for treating Factor VII-mediated conditions.
    Type: Application
    Filed: October 2, 2001
    Publication date: September 26, 2002
    Inventors: Hans Kurt Pingel, Niels Kristian Klausen
  • Thrombin-activated tissue plasminogen activators
    Patent number: 5200340
    Abstract: Zymogens of proteins having fibrinolytic activity are disclosed. The proteins are cleavable by thrombin, the cleavage resulting in the stimulation of fibrinolytic activity. Suitable proteins which may be modified in accordance with the present invention include tissue plasminogen activator, urokinase, and plasminogen variants. The modified molecules are substantially clot-specific, in view of the large amounts of thrombin associated with clots in vivo.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: April 6, 1993
    Assignee: ZymoGenetics, Inc.
    Inventors: Donald C. Foster, Eileen R. Mulvihill, Patrick J. O'Hara, Kurt Pingel, Shinji Yoshitake